Polyclonal Antibody to Tafazzin (TAZ)
Ref: CC-PAE564Ra01-100 ul
CMD3A; EFE2; EFE; BTHS; XAP-2; G4.5; Barth syndrome; Endocardial Fibroelastosis 2; Cardiomyopathy,Dilated 3A(X-Linked)
Información del producto
Información adicional
Size
100 ul
Applications
WB
Detection Range
Rabbit
Sensitivity
100 ul
Research Area
Cardiovascular biology
Immunogen
RPE564Ra01-Recombinant Tafazzin (TAZ)
Organism species
Rattus norvegicus (Rat)
Alternative Names
CMD3A
Item Name
Tafazzin
Assay Length
Cardiovascular biology
Sample Type
WB
Host
Rabbit
Assay procedure summary
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
UniProt ID
Q4KLG6
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Usage
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
Tissue Source
Polyclonal antibody preparation